To establish the clinical validity of multiplexed analyses of variant effect (MAVEs) for interpreting and reclassifying variants in Lynch syndrome, we intersected loss-of-function (LoF) scores from a deep mutational scan of MSH2 [26] with a clinical database of 1604 individuals with MMR gene variants detected by paired tumor and germline testing. This evidence concerns the gene MRC1 and neoplasm.